Company / Depreciation & Amortization
ENDRA Life Sciences Inc. Depreciation & Amortization History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$99.3K
FY2020
5-year range
$61.5K / $99.3K
FY2017-FY2020
Trend
+45.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $61,481 to $99,342 over the past 2 years.
Based on SEC 10-K filings.
$99,342 in FY2020 with a 3-year CAGR of +17.3%.
Increased from $61,481 to $99,342 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +17.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +17.3%, indicating consistent growth.
- In FY2020, depreciation & amortization increased 45.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $99.3K | +45.4% |
| FY2019 | $68.3K | +11.1% |
| FY2018 | $61.5K | +0.0% |
| FY2017 | $61.5K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026